These features included PVs in BRCA1/BRCA2 for breast and ovarian cancer, PVs in TP53 for sarcoma, breast and other Li-Fraumeni-related cancers, or lobular breast cancer which is more common with CDH1 PVs. This evidence concerns the gene BRCA1 and ovarian cancer.